ProShare Advisors
EIDX

ProShare Advisors’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

ProShare Advisors’s Portfolio EIDX Stock Details EIDX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$1.1M Buy
2020
Q3 		$382K Sell
2020
Q2 		$364K Buy
2020
Q1 		$285K Sell
2019
Q4 		$553K Sell
2019
Q3 		$404K Sell
2019
Q2 		$387K Sell
2019
Q1 		$334K Buy
2018
Q4 		$182K Buy